Construction and characterization of two versions of bifunctional EGFP-sTRAIL fusion proteins

Applied Microbiology and Biotechnology

Volumn 76, Issue 1, 2007, Pages 141-149

  Shen, Jiayin ^a   Wu, Yifan ^a   Shi, Lijun ^a   Liu, Junhong ^a   Liu, Shunyi ^a   Guan, Zhengbing ^a   Yin, Zhimin ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Enhanced fluorescent protein; Human TNF related apoptosis inducing ligand; Receptor binding

Indexed keywords

AMINO ACIDS; BINDING ENERGY; FUSION REACTIONS; LIGANDS; TUMORS;

ENHANCED FLUORESCENT PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; HUMAN TNF-RELATED APOPTOSIS-INDUCING LIGANDS; LYMPHOIDS; RECEPTOR BINDING;

PROTEINS;

ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AMINO ACID; FLOW CYTOMETRY; GENE; LIGAND; PROTEIN;

APOPTOSIS; ARTICLE; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; LEUKEMIA CELL LINE; LYMPHATIC SYSTEM TUMOR; NONHUMAN; TUMOR CELL LINE;

APOPTOSIS; ESCHERICHIA COLI; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; JURKAT CELLS; PROTEIN BINDING; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 34547608162     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-007-1001-1     Document Type: Article

References (30)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162
2. Cao P, Zhang S, Zhang J, Wang M (2006) Construction and characterization of a bi-functional EGFP/sBAFF fusion protein. Biochimie 88:629-635
3. Chalfie M (1995) Green fluorescent protein. Photochem Photobiol 60:651-656
4. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC (1994) Green fluorescent protein as a marker for gene expression. Science 263:802-805
5. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kB pathway. Immunity 7:821-830
6. Cormack BP, Valdivia RH, Falkow S (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene (Amst) 173:33-38
7. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY (1995) Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 20:448-455
8. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA (1997) Cloning and characterization of TRAIL-R3 a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165-1170
9. Di Pietro R, Secchiero P, Rana R, Gibellini D, Visani G, Bemis K, Zamai L, Miscia S, Zauli G (2001). Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1. Blood 97:2596-2603
10. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, JamesIE, Rosenberg M, Lee JC, Young PR (1998) Osteoprotegerinis a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363-14367
11. Heim R, Prasher DC, Tsien RY (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA 91:12501-12504
12. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564-567
13. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H (1999a) Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med 189:1451-1460
14. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H (1999b) Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J Immunol 162:2639-2647
15. Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H (1999c) Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 163:1906-1913
16. Laemmli UK (1970) Cleavage of structural proteins during assembly of the heat of bacteriophage T4. Nature 277:680-685
17. Marshall J, Molloy R, Moss GW, Howe JR, Hughes TE (1995) The jellyfish green fluorescent protein, a new tool for studying ion channel expression and function. Neuron 14:211-215
18. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Pinerio A, Naval J, Anel A (1998) Involvement of APO2/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 28:2174-2725
19. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997a) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818
20. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM (1997b) The receptor for the cytotoxic ligand TRAIL. Science 276:111-113
21. Pan G, Ni J, Yu G, Wei YF, Dixit VM (1998) TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL. FEBS Lett 424:41-45
22. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690
23. Rosorius O, Heger P, Stelz G, Hirschmann N, Hauber J, Stauber RH (1999) Direct observation of nucleo-cytoplasmic transport by microinjection of GFP-tagged proteins in living cells. Biotechniques 27:350-355
24. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16:5386-5397
25. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999a) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163
26. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999b) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163
27. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
28. Wu GS, Burns TF, McDonald ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El-Deiry WS (1997) KILLER /DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17:141-143
29. Yang TT, Cheng L, Kain SR (1996) Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res 24:4592-4593
30. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B (1998) Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 188:2375-2380